Zydus receives final approvals from USFDA for Ivermectin Tablets USP
Ivermectin Tablets USP, 3 mg, are prescription anti-parasitic medications primarily indicated for treating parasitic worm infections in humans
Ivermectin Tablets USP, 3 mg, are prescription anti-parasitic medications primarily indicated for treating parasitic worm infections in humans
Emcure to distribute Roche's kidney transplant and anemia drugs in India
The decision marks a pivotal moment for the Massachusetts-based biotech giant
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
The construction projects, which have already begun, will be finalised gradually from the end of 2027 through 202
The facility is expected to become operational by FY2028-29
Fenebrutinib has the potential to become the first and only high-efficacy oral, brain-penetrant treatment for both RMS and PPMS, showing a profound benefit on relapsing and progressive disease biology
The partnership will focus on the ongoing SYNERGY-101 randomized Phase 2 trial for first-line
The EIR was issued following an inspection of the facility from November 10 to November 21, 2025
Subscribe To Our Newsletter & Stay Updated